Objectives: The investigation centers on whether there is a reperfusion-induced specific cardiac inflammatory reaction after bypass surgery. Background: Cardiopulmonary bypass (CPB) leads to systemic inflammation. Additionally, cardiac inflammation due to reperfusion could occur. Knowledge about nature and time course of this reaction might help to develop cardioprotective interventions. Methods: In 12 patients receiving coronary bypass grafts, arterial and coronary venous blood was obtained before onset of CPB, and 1, 5, 10, 25, 35 and 75 min after cardiac reperfusion. Plasma levels of IL6 and IL8 were measured by immunoassay. CD11b, CD41, and CD62 on blood cells were quantified by flow cytometry. Measurement of CD41, a platelet marker, on neutrophils and monocytes allowed detection of leukocyte-platelet microaggregates. Results: Transcardiac veno-arterial difference of IL6 rose in the 10th and 25th min of reperfusion (from 0 to 7 pg / ml; p,0.05), and after 75 min (15 pg / ml). IL8 did not change. CD11b on neutrophils (PMN) decreased transcardially to 95, 88 and 82% of the initial level in the 5th, 10th, and 75th min, respectively, suggesting sequestration of activated neutrophils. CD62 on platelets rose about 30% in the 75th min. Initially, leukocyte-platelet microaggregates were formed during coronary passage (131% of the arterial level for PMN, 123% for monocytes). During reperfusion, coaggregates were retained (PMN: 21% and 27% in the 5th and 10th min, monocytes: 222%, 213% and 212% in the 1st, 5th and 10th min. Conclusions: During early reperfusion after aortic declamping, the coronary bed is already a source of proinflammatory stimuli and target for activated leukocytes, partly in conjunction with platelets. Mitigation of these phenomena might help to improve cardiac function after CPB especially in patients at risk.
Introduction
solutions [7] . However, the possible role of the heart as a source of inflammatory stimuli and as a target of inflamNumerous experimental and clinical studies have demmation in the clinical situation of CPB is less well onstrated that cardiopulmonary bypass (CPB) leads to a characterized. This could be relevant, because after aortic systemic inflammatory response, characterized by activadeclamping global cardiac reperfusion occurs, and reperfution of neutrophils [1] and platelets [2] , formation of sion, as such, represents a massive proinflammatory leukocyte-platelet coaggregates [3, 4] , and elevation of stimulus in the heart [8, 9] . In turn, different features of cytokine plasma levels [5] . The main reasons for this inflammation depress cardiac performance: intracoronary generalized inflammation are the contact of blood with retention and activation of neutrophils represents a main artificial surfaces in components of the extracorporeal aspect of reperfusion injury [11] , while some cytokines circulation apparatus [6, 7] , and the influence of priming have direct negative inotropic effects [10] . Consequences of reperfusion injury, such as myocardial stunning and coronary low-reflow, might, thus, infringe the clinical Table 1 benefit of interventions employing extracorporeal circulaa Clinical characteristics and pre-medication of the study patients tion and clamping of the aorta. Indeed, antiinflammatory Age 6462 years medication [12] and removal of leukocytes from the Sex 3 women, 9 men circulation [13] seem to have beneficial effects on carEjection fraction 6763% diovascular function after CPB.
Duration of ischemia (min) 5265
Transcardiac inflammation has already been described in angioplasty under stable [14] or post-infarction conditions Diabetes 3 [9] . There even seems to be a causal link between acute Aspirin 12 inflammatory responses during reperfusion (formation of Nitrates 11 leukocyte-platelet aggregates) and the occurrence of reBeta-blockers 10 stenosis [14] . In the present study, we investigated in- before extracorporeal circulation and after the 1st, 5th, 10th, 25th, 35th and 75th min of reperfusion after aortic declamping. In detail, we analyzed plasma levels of cytokines (IL6 and IL8) and activation markers on 2.3. Blood samples leukocytes (CD11b, a subunit of the adhesion molecule Mac-1) and platelets (CD41, a subunit of the GPIIb / IIIa Blood samples (3 ml each) were drawn simultaneously receptor, and CD62, i.e. P-selectin), and determined the from the cannulated radial artery and from the coronary percentage of platelet-carrying leukocytes in systemic sinus catheter: before administration of heparin, after the arterial and coronary venous blood. Furthermore, trans1st, 5th and 10th min after release of the aortic cross coronary differences of the soluble form of the adhesion clamp, as well as after release of the Lambert-Kay clamp molecule ICAM-1, and of leukocyte-and platelet-counts (about 25th min of reperfusion), after application of were measured.
protamine (about 35th min), and after 75 min of reperfusion. A multi-purpose catheter with a 5-cm tip (708 angle) was used for blood sampling. The dead space of the catheter being about 1 ml, the first 5 ml of every sample 2. Methods were discarded. The correct transcutaneous emplacement of the coronary sinus catheter was monitored by observing 2.1. Patients the pressure curve of the catheter and by measuring oxygen saturation of the blood samples. The pressure 12 patients, ,75 years old, undergoing elective coronary curves had to show a venous pattern throughout, and artery bypass graft surgery and with an ejection fraction oxygen saturation had to be in the range of 25-40% for .55% entered the study, which was approved by our inclusion of the samples in the study. institutional ethics committee. The study was performed according to the latest amendment of the Declaration of Helsinki. All patients gave their written informed consent 2.4. Immunoassays for inclusion in the study. Exclusion criteria were myocardial infarction within 14 days before the operation, inImmediately after sampling, an aliquot of the blood (2 flammatory diseases or intake of immunosuppressants. The ml) was stored on ice until centrifugation at 2000 g for 10 clinical characteristics of the study patients are summamin to obtain platelet poor plasma. This was stored at rized in Table 1 .
2208C until final processing. Concentrations of IL6 and IL8 were determined by sandwich type immunoassays (Endogen). In both cases standards covered a range from 0 2.2. Anesthesia and surgery to 1000 pg / ml. Soluble ICAM-1 was also measured by ELISA (T Cell The patients were anaesthetized with either sufentanil1 Diagnostics). In this case samples had to be diluted 1:100 midazolam, sufentanil1propofol, or remifentanil1 to reach the optimum sensitivity of the assay (0.3 ng / ml). midazolam; no volatile anaesthetics were used. OxygenDue to continuous hemodilution during the surgical ation of the blood was performed with bubble oxygenators intervention, all measured concentrations had to be cor-(Dideco, Mirandola, Italy). After initiation of extracorporerected to the hematocrit of the arterial pre-heparin sample al circulation, the blood was cooled to 26 Leukocytes were pelleted for 5 min at 200 g, washed The arterial levels of IL6 rose continuously, from ,0.1 with Cellwash (Becton Dickinson), pelleted again, and pg / ml before the intervention, to 110 pg / ml after 75 min then double-stained with phycoerythrin (PE) conjugated of reperfusion (Fig. 1A) . Under basal conditions, there was anti-CD11b antibodies (Exalpha) and with FITC labelled no transcardiac concentration difference of IL6. In the 10th anti-CD41 antibodies (Serotec). The measurement of the and 25th min of reperfusion, however, significant venoplatelet marker CD41 on leukocytes served to determine arterial differences of IL6 (7 pg / ml) were to be detected. the percentage of neutrophils and monocytes carrying This increase of IL-6 concentration rose further to about 15 platelets. After incubation with the antibodies for 15 min pg / ml in the 75th min of reperfusion (Fig. 1B) . in the dark, cells were washed, centrifuged and resuspend-
The arterial content of IL8 was 8 pg / ml pre-operatively, ed in Cellwash, prior to measurement.
and rose continuously until the 35th min of reperfusion (50 For the analysis of platelets the fixed blood suspension pg / ml), i.e. up to the application of protamine. Arterial was centrifuged at 1200 g for 5 min. The supernatant was IL8 then declined to 30 pg / ml in the 75th min (Fig. 1C ). discarded and the pellet resuspended in 1 ml Cellwash. A There was no statistically significant coronary veno-arterial 50-ml volume of this suspension was incubated with difference for IL8 at any time point (Fig. 1D ). antibodies against CD41 (FITC labelled, Serotec) and CD62 (PE conjugated, Harlan Seralab) for 15 min in the dark. Cells were then centrifuged at 1200 g for 5 min, 3.2. Expression of CD11b washed with Cellwash, centrifuged again, finally resuspended in 500 ml Cellwash, and measured.
On neutrophils, expression of CD11b in arterial samples Flow cytometry was performed with a FACScan and rose to about 140% of the basal level in the 25th min of Lysys II software (Becton Dickinson). Ten thousand reperfusion, then declined again to the initial level (Fig. events were acquired for each sample. Neutrophils, mono-2A). Monocytes showed a similar behaviour on a lower cytes and platelets were discriminated by their characterislevel of activation (Fig. 2C ). CD11b expression was lower tic pattern of forward and sideward scatter, and separately on neutrophils emerging from the coronary system during analysed after setting appropriate gates. The mean fluoresinitial reperfusion (1st, 5th, 10th min) than the correcence intensity was taken as a measure of antibody sponding arterial values, and then again during later binding. Reproducibility was ensured by regular calibrareperfusion (75th min, Fig. 2B ). The early response of tion of the flow cytometer. The non-specific background monocytes (1st, 5th, 10th min) was similar, but the v-a was quantified by measurement of the fluorescence intensidifference did not reach statistical significance (Fig. 2D) . ty of samples labelled with non-binding isotype matched antibodies (mouse IgG1-PE from SBA, Birmingham, USA, 3.3. Soluble ICAM-1 and mouse IgG2a-FITC from Exalpha), and subsequently subtracted.
To check whether changes in CD11b detectability could The considerable variability of both leukocyte and arise from masking of this molecule by different levels of platelet markers in the study population, even under basal its soluble ligand sICAM-1 in the plasma, we also meaconditions, made it necessary to normalize fluorescence sured plasma levels of sICAM-1 during early reperfusion. intensities. The pre-interventional arterial value of each
The basal arterial concentration of sICAM-1 was 200 individual -termed basal in the following -was set as ng / ml, and did not change significantly during the first 100% for every flow cytometric parameter. All changes are minutes of reperfusion (Fig. 3A) . A coronary veno-arterial therefore given in percentages.
difference of sICAM-1 was detected in the 10th min of reperfusion (20 pg / ml), but not at earlier time points (Fig.  2.6 . Statistical analysis 3B). The transcardiac rise in plasma levels at 10 min amounted to about 10%. The given veno-arterial differences are means of individually calculated differences, and not differences of mean values. All results are expressed as means6S.E.M.
3.4. Platelet activation markers ANOVA for repeated measurements was applied for the comparison of values at different time points with the basal The surface expression of both platelet activation markers, CD62 (P-selectin) and CD41 (gpIIb / IIIa), increased rapidly on arterial platelets, with the maxima after protamine administration in the 35th min of reperfusion ( Fig. 4A and C) . Coronary passage led to neither a significant loss nor upregulation of the two markers during early reperfusion ( Fig. 4B and D) . However, a rise of CD62 expression of 25% above baseline was observed in the 75th min of reperfusion (Fig. 4B) .
Leukocyte-platelet interaction
During the first 25 min of reperfusion, the occurrence of neutrophil-platelet coaggregates in arterial blood (measured as percentage CD41 positive neutrophils) was markedly elevated vs. the basal state before CPB and later time points (Fig. 5A) . The same was true for monocyte-platelet coaggregates, however with a more protracted time course, and on a much higher level, with up to 60% of the arterial monocytes carrying platelets, as compared to maximally 15% for neutrophils ( Fig. 5A and C) . The coronary venoarterial difference of leukocyte-platelet microaggregates was positive under basal conditions ( Fig. 5B and D) , i.e., new aggregates were being formed during coronary passage (31% increase vs. arterial values for PMN, 23% neutrophil-and monocyte-platelet aggregates, decreased 4. Discussion significantly below these basal values ( Fig. 5B and D) . In fact, less aggregates were emerging from the coronary The present study demonstrates that, after CPB, the system than were entering it (negative v-a-difference).
human heart is a site of postischemic inflammation and a source of proinflammatory stimuli. Findings leading to this 3.6. Cell counts conclusion are (I) increase of IL6 concentrations after coronary passage early in reperfusion, (II) trapping of The time courses of the veno-arterial differences for CD11b positive leukocytes in the coronary system, and leukocytes and platelets are given in Table 2 . In the 1st (III) trapping of leukocyte / platelet aggregates in the min of reperfusion, as well as immediately after reperfucoronary bed during initial reperfusion. These effects occur sion of the grafts (about 25th min), there was a tendencial in addition to the systemic inflammatory changes evoked increase of both leukocyte and platelet counts during by the extracorporeal circulation. coronary passage. At all other time points, leukocytes tended to be retained in the coronary system. However, 4.1. Cytokines statistically significant retention (Table 2 ) was attained only after 35 min (platelets) and 75 min (leukocytes).
A systemic increase of the cytokines IL6 and IL8 due to extracorporeal circulation has already been reported by a number of authors [1, 5, 15] . In our present study, we have minutes of reperfusion. This finding conflicts with the found similar systemic increases of both IL6 and IL8 in the upregulation of CD11b (i.e. activation of PMN) observed blood of patients undergoing cardiopulmonary bypass (Fig. during coronary passage after myocardial infarction and 1A and C). In addition to this systemic response, the PTCA [9] . Lower mean expression of CD11b could mean cardiac production and release of cytokines might be of (A) deactivation of leukocytes, (B) masking of CD11b by special interest, because cytokines act negatively inotropic binding of a soluble physiologic ligand, or (C) retention of [10] . They could, thus, directly contribute to myocardial the most activated leukocytes in the reperfused coronary stunning. Moreover, the cytokines produced by the heart system. Hypothesis (A) is very improbable, because no itself could further locally upregulate coronary endothelial mechanism has been described for a rapid downregulation adhesion molecules [16] , leading to retention and activaof CD11b (proteolytic shedding, as in the case of Ltion of passing leukocytes, and generate a chemotactic selectin, does not seem to occur). To test the second gradient for inflammatory cells into the cardiac parenhypothesis (B), we measured transcardiac concentrations chyma. Indeed, rapid cardiac release of the cytokines IL6 of soluble ICAM-1, a natural ligand for CD11b [22] . and IL8 has been shown in humans after myocardial However, after 5 min of reperfusion, when there already infarction and subsequent recanalization, and has been was a notable decrease of CD11b, no enhanced venointerpreted as a sign of postischemic cardiac inflammation arterial differences of sICAM-1 were to be found (Fig.  [9] . In experimental models of cardiac ischemia and 3B). Interestingly, there was a significant rise of sICAM-1 reperfusion, the induction of IL6-and IL8-mRNA has been after 10 min of reperfusion. This may well be taken as a demonstrated [8, 17] , and during pediatric CPB, the inducsign of endothelial activation. To date, however, there is no tion of IL8 in human heart muscle has been shown [18] .
consensus on the pathophysiological significance of the In our study we have, for the first time, measured presence of soluble adhesion molecules in plasma. With coronary veno-arterial differences of IL6 and IL8 levels respect to explanation (C), an actual sign of leukocyte during acute post-crossclamp reperfusion. Surprisingly, retention is the tendencially negative veno-arterial differ-IL6 concentrations rose during coronary passage already ence of leukocyte counts at those time points, at which after 10 and 25 min of reperfusion (Fig. 1B) , a timepoint CD11b decreased most (Table 2) . One has, however, to much too early to allow de novo synthesis of a protein.
keep in mind that leukocyte adhesion does not necessarily The absence of this effect in the case of IL8 (Fig. 1D) depend on upregulation of surface CD11b, but can also be suggests that it was no mere washout phenomenon after induced by an increase of CD11b affinity [23] . Thus, a ischemia, but the specific increase of a proinflammatory strict correlation of CD11b expression and leukocyte agent. Thus, it may be concluded that preformed IL6 has retention may not be expected. been released from cardiac tissue, with cardiac endothelial
The partial conflict of these results with previous data cells or macrophages being the most likely sources. In [9] suggests that different clinical forms of myocardial contrast to this early rise of IL6, the secondary increase ischemia and reperfusion (e.g. acute myocardial infarction after 75 min might well be due to gene induction by and subsequent rescue PTCA as compared to cardioplegic reperfusion [8] .
global ischemia during cardiosurgery) might well result in quite different extents and relations of leukocyte activation and retention. The pathophysiological consequences have 4.2. Activation of leukocytes still to be evaluated.
Leukocytes, especially neutrophils (PMN), are widely accepted as one of the main causes for reperfusion injury 4.3. Activation of platelets [11] . After adhesion to endothelium, they are chemotactically activated, transmigrate through the endothelial barrier During reperfusion of previously ischemic myocardium, and undergo a so-called 'burst reaction' [19] , liberating activated platelets with their thrombotic potential are a risk proteolytic enzymes and reactive oxygen species. These factor for restenosis [24] . Furthermore, anti-platelet drugs processes cause microvascular leakage, vasoconstriction have turned out to be promising tools in the prevention of and, ultimately, tissue damage [20] . Extracorporeal circulareocclusion [25] . During CPB, marked activation of tion leads to rapid upregulation of CD11b (1), an early platelets has been described [2] . In our study, we measured activation marker on leukocytes and an adhesion molecule the surface expression of two activation markers on which is important for the attachment of leukocytes to the platelets: the adhesion molecule CD62 or P-selectin, which endothelium [21] . We, too, observed the systemic upreguenables platelets to adhere to leukocytes [26] , and CD41, a lation of CD11b on both PMN and monocytes during CPB subunit of the integrin GPIIb / IIIa [27] . Both adhesion ( Fig. 2A and C) . However, this increase was transient, molecules have been described to be rapidly upregulated probably due to the retention of the most activated on platelets upon stimulation [26, 27] . We have found both leukocytes in the tubing and the oxygenator of the CPB. markers to be upregulated systemically throughout reperfuThe transcardiac difference for CD11b on PMN and sion, with a peak after protamine application ( Fig. 4A and (tendencially) on monocytes was negative during the first C). Furthermore, we investigated whether global myocar- dial reperfusion after cardioplegia leads to a specific to other organs, has by far the most important conseactivation of platelets during coronary passage. Surprisingquences for the clinical outcome of cardiothoracic surgery. ly, mean veno-arterial differences of both P-selectin and gpIIb / IIIa tended to be negative during early reperfusion. 4.5. Pathophysiological implications This would suggest retention of activated platelets in the coronary system rather than washout of activated thromIn the present study we found signs of very rapid bocytes. In the 5th min of reperfusion, the negative venopostischemic cardiac inflammation. In the first minutes of arterial difference of platelet counts ( Table 2 , not signifireperfusion, a net trans-coronary increase of IL6 and cant) strengthens this hypothesis.
sequestration of activated neutrophils and of leukocyteThe clear retention of platelets in the coronary system platelet coaggregates occurred in the coronary system. A after administration of protamine (Table 2) correlates with second wave of these inflammatory responses took place at a transient decrease of veno-arterial CD41 and CD62 later time points, namely with the application of protamine levels (Fig. 4) . In a later phase of reperfusion (75 min, and after onset of reperfusion of the fresh grafts. This time about 40 min after the onset of blood passage through the course suggests that reperfusion injury is a consequence of new grafts), P-selectin was markedly upregulated by a positive feedback, initiated by early reperfusion. This coronary passage, indicating platelet activation, and, perearly phase could induce expression of pro-inflammatory haps, beginning of acute reocclusion (Fig. 4B) .
genes, and, thus, set the stage for later events. If coronary retention of activated leukocytes and platelets during early reperfusion really is the trigger for the subsequent 4.4. Leukocyte-platelet interaction pathophysiologic effects, patients might greatly profit from anti-inflammatory and anti-platelet interventions during, Over the last years awareness has grown that blood cell and early after cardiosurgery. populations do not act independently, and that mutual
The crucial point of future studies has to be, how far the functional modulation is common. For example, platelets experimental findings on inflammatory parameters correreadily adhere to leukocytes, priming them for subsequent late with the individual clinical outcome after coronary chemotactic stimulation [26, 28] . The formation of such bypass surgery. leukocyte-platelet coaggregates has been shown after coronary angioplasty, and may even be a predictor for the development of restenosis [14] . Also in the situation of
